Treatment of the Serotonin Syndrome with Cyproheptadine
Authors:
- Richard I. LappinRLRichard I. Lappin
- Elizabeth L. AuchinclossEAElizabeth L. Auchincloss
- 13 October 1994
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 331 (15) , 1021-1022
Abstract
The serotonin syndrome consists of behavioral, neuromuscular, and autonomic changes that result from increased activity of serotonin (5-hydroxytryptamine) in the central nervous system.1 Its symptoms and signs include confusion, fever, diaphoresis, hyperreflexia, ataxia, and myoclonus. The syndrome usually results from the concurrent use of two serotonergic medications, most often a monoamine oxidase inhibitor and either tryptophan or an inhibitor of serotonin reuptake, such as fluoxetine (Prozac) or sertraline (Zoloft). Because of the long-lasting serotonergic activity of both monoamine oxidase inhibitors and inhibitors of serotonin reuptake, however, the syndrome can occur when one drug is discontinued and the other is started weeks later. With supportive therapy alone, the syndrome usually resolves completely within 24 hours after discontinuation of the drug, but prolonged symptoms and even fatal outcomes have occurred.Keywords
This publication has 2 references indexed in Scilit:
- The serotonin syndromeAmerican Journal of Psychiatry, 1991
- L-Dopa Induced ???Serotonin Syndrome??? in a Parkinsonian Patient on BromocriptineJournal of Clinical Psychopharmacology, 1986